Eli Lilly Corp. diskutieren
Eli Lilly Corp.
WKN: 858560 / Symbol: LLY / Name: Eli Lilly / Aktie / Pharmazeutika / Large Cap /
1.008,4 €
-0,04 %
Eli Lilly and Company (LLY) had its "buy" rating reaffirmed by Jefferies Financial Group Inc..
Ratings data for LLY provided by MarketBeat
Eli Lilly and Company (LLY) had its "outperform" rating reaffirmed by BMO Capital Markets.
Ratings data for LLY provided by MarketBeat
Eli Lilly and Company (LLY) had its "overweight" rating reaffirmed by Cantor Fitzgerald.
Ratings data for LLY provided by MarketBeat
Eli Lilly and Company (LLY) had its price target raised by Cantor Fitzgerald from $1,230.00 to $1,350.00. They now have an "overweight" rating on the stock.
Ratings data for LLY provided by MarketBeat
Eli Lilly and Company (LLY) had its price target raised by JPMorgan Chase & Co. from $1,300.00 to $1,400.00. They now have an "overweight" rating on the stock.
Ratings data for LLY provided by MarketBeat
Eli Lilly and Company (LLY) had its "overweight" rating reaffirmed by Morgan Stanley.
Ratings data for LLY provided by MarketBeat
Eli Lilly and Company (LLY) had its price target raised by Royal Bank Of Canada from $1,250.00 to $1,500.00. They now have an "outperform" rating on the stock.
Ratings data for LLY provided by MarketBeat
Eli Lilly and Company (LLY) was given a new $1,370.00 price target by Truist Financial Corporation. They now have a "buy" rating on the stock.
Ratings data for LLY provided by MarketBeat
Eli Lilly and Company (LLY) had its price target raised by Bank of America Corporation from $1,251.00 to $1,334.00. They now have a "buy" rating on the stock.
Ratings data for LLY provided by MarketBeat
Eli Lilly and Company (LLY) had its price target raised by Guggenheim from $1,235.00 to $1,273.00. They now have a "buy" rating on the stock.
Ratings data for LLY provided by MarketBeat
Eli Lilly and Company (LLY) had its "buy" rating reaffirmed by UBS Group AG.
Ratings data for LLY provided by MarketBeat
Eli Lilly and Company (LLY) had its "outperform" rating reaffirmed by Sanford C. Bernstein.
Ratings data for LLY provided by MarketBeat
Eli Lilly and Company (LLY) had its price target raised by Sanford C. Bernstein from $1,300.00 to $1,385.00. They now have an "outperform" rating on the stock.
Ratings data for LLY provided by MarketBeat
Eli Lilly and Company (LLY) had its "buy" rating reaffirmed by Citigroup Inc..
Ratings data for LLY provided by MarketBeat
Neueste Beiträge
Jefferies_Financial_ in M&T Bank Corp. diskutieren